124 related articles for article (PubMed ID: 36354241)
1. Oral magnesium sulphate administration in rats with minimal hepatic encephalopathy: NMR-based metabolic characterization of the brain.
Liu XF; Lu JJ; Li Y; Yang XY; Qiang JW
Magnes Res; 2022 Apr; 35(2):39-50. PubMed ID: 36354241
[TBL] [Abstract][Full Text] [Related]
2. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy.
Li Y; Mei LH; Qiang JW; Ji CX; Ju S
Neuroscience; 2017 Apr; 347():148-155. PubMed ID: 28193543
[TBL] [Abstract][Full Text] [Related]
3. Ferrous sulfate reverses cerebral metabolic abnormality induced by minimal hepatic encephalopathy.
Liu XF; Lu JJ; Li Y; Yang XY; Qiang JW
Metab Brain Dis; 2023 Jun; 38(5):1613-1620. PubMed ID: 36917427
[TBL] [Abstract][Full Text] [Related]
4. MR T1 mapping for quantifying brain manganese deposition in type C hepatic encephalopathy rats.
Zhang C; Li Y; Lu J; Yang X; Wang J; Qiang J
Biometals; 2021 Aug; 34(4):841-854. PubMed ID: 33928475
[TBL] [Abstract][Full Text] [Related]
5. The interaction of ammonia and manganese in abnormal metabolism of minimal hepatic encephalopathy: A comparison metabolomics study.
Liu XF; Lu JJ; Li Y; Yang XY; Qiang JW
PLoS One; 2023; 18(8):e0289688. PubMed ID: 37540683
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR- and MS-based metabolomics study.
Lu J; Li Y; Zhang C; Yang X; Qiang J
Biometals; 2022 Oct; 35(5):935-953. PubMed ID: 35857253
[TBL] [Abstract][Full Text] [Related]
7. Decreased brain noradrenaline in minimal hepatic encephalopathy is associated with cognitive impairment in rats.
Yang X; Liu W; Dang P; Wang Y; Ge X; Huang X; Wang M; Zheng J; Ding X; Wang X
Brain Res; 2022 Oct; 1793():148041. PubMed ID: 35944657
[TBL] [Abstract][Full Text] [Related]
8. [Effect of dopamine on intracerebral glutamate uptake ability in rats with minimal hepatic encephalopathy and the pathogenesis of minimal hepatic encephalopathy].
Wen FF; Xu Z; Liu LP; Yang JJ; Ding SD
Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):48-53. PubMed ID: 29804362
[No Abstract] [Full Text] [Related]
9. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of trace element magnesium significantly improving the cognition and locomotion in hepatic encephalopathy rats.
Li Y; Ji CX; Mei LH; Qiang JW; Ju S
Sci Rep; 2017 May; 7(1):1817. PubMed ID: 28500320
[TBL] [Abstract][Full Text] [Related]
11. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
[TBL] [Abstract][Full Text] [Related]
12. Main target of minimal hepatic encephalopathy: Morphophysiological, inflammatory and metabolic view.
Arias N; Méndez M; Gómez-Lázaro E; Azpiroz A; Arias JL
Physiol Behav; 2015 Oct; 149():247-54. PubMed ID: 26079568
[TBL] [Abstract][Full Text] [Related]
13. Disturbance of thalamic metabolism and its association with regional neural dysfunction and cognitive impairment in minimal hepatic encephalopathy.
Chen LH; Shi JY; Zou TX; Zhang L; Gou Y; Lin Y; Chen HJ
Eur J Radiol; 2020 Oct; 131():109252. PubMed ID: 32949859
[TBL] [Abstract][Full Text] [Related]
14. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
[TBL] [Abstract][Full Text] [Related]
15. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
16. Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy.
Ding S; Huang W; Ye Y; Yang J; Hu J; Wang X; Liu L; Lu Q; Lin Y
Mol Med Rep; 2014 Sep; 10(3):1215-24. PubMed ID: 25059564
[TBL] [Abstract][Full Text] [Related]
17. Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy.
Ding S; Zhuge W; Yang J; Wen F; Xu Z; Wang X; Zhuge Q
Toxicol Sci; 2017 Oct; 159(2):290-306. PubMed ID: 28505381
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
19. The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution.
Yang X; Dang P; Liu W; Ma W; Ge X; Zhu K; Wang M; Huang X; Ding X; Wang X
Front Neurol; 2022; 13():900997. PubMed ID: 36341087
[TBL] [Abstract][Full Text] [Related]
20. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.
Jia L; Zhang MH
World J Gastroenterol; 2005 Feb; 11(6):908-11. PubMed ID: 15682492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
